These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 1655284)

  • 41. Association of partial gonadal dysgenesis, nephropathy and WT1 gene mutation without Wilms' tumor: incomplete Denys-Drash syndrome.
    Cetinkaya E; Ocal G; Berberoğlu M; Adiyaman P; Ekim M; Yalçinkaya F; Orün E
    J Pediatr Endocrinol Metab; 2001 May; 14(5):561-4. PubMed ID: 11393579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
    Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
    Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
    Chiang PW; Aliaga S; Travers S; Spector E; Tsai AC
    Curr Opin Pediatr; 2008 Feb; 20(1):103-6. PubMed ID: 18197048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ
    FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
    Zhai G; Iskandar M; Barilla K; Romaniuk PJ
    Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
    Tsuchida Y; Yokomori K; Choi SH
    Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.
    Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI
    Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
    Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical mutation in both WT1 alleles is not sufficient to cause Wilms' tumor.
    Kikuchi H; Akasaka Y; Kurosawa Y; Yoneyama H; Kato S; Hata J
    FEBS Lett; 1995 Feb; 360(1):26-8. PubMed ID: 7875294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins.
    Dharnidharka VR; Ruteshouser EC; Rosen S; Kozakewich H; Harris HW; Herrin JT; Huff V
    Pediatr Nephrol; 2001 Mar; 16(3):227-31. PubMed ID: 11322369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
    Zhu C; Zhao F; Zhang W; Wu H; Chen Y; Ding G; Zhang A; Huang S
    Eur J Pediatr; 2013 Oct; 172(10):1357-62. PubMed ID: 23715653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
    Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
    J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
    Maiti S; Alam R; Amos CI; Huff V
    Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. WT1 and glomerular diseases.
    Niaudet P; Gubler MC
    Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
    Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
    Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.